Martin S Kluger PhD

Research Scientist in Immunobiology

Departments & Organizations

Office of Student ResearchVascular Biology and Therapeutics ProgramImmunobiology

Research Interests

Sepsis; Vascular Hyperpermeability (leak); Tumor Necrosis Factor (TNF); Interleukin-1 (IL-1); Claudin-5; Microvascular Endothelial Cells; NF-κB signaling more...


  • Ph.D., University of Connecticut, 1994

Selected Publications

  • Abrahimi, P., Chang, WG., Kluger, MS., Qyang, Y., Tellides, G., Saltzman, WM., and Pober, J.S. Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. 2015. Circulation Research (Accepted for Publication)
  • Clark P.R., Kim R.K., Pober J.S., and Kluger M.S. Tumor Necrosis Factor Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-kappaB-Dependent Phases. 2015. PLOS ONE, PLoS ONE 10(3): e0120075. doi:10.1371/journal.pone.0120075
  • Kluger MS, Clark PR, Tellides G, Gerke V, Pober JS. Claudin-5 Controls Intercellular Barriers of Human Dermal Microvascular but not Human Umbilical Vein Endothelial Cells. 2013. Arteriosclerosis, Thrombosis, and Vascular Biology 33:489-500. Click to view: Access the recommendation on F1000Prime



Latest News


Edit Profile